Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

80 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Cost-effectiveness of percutaneous coronary intervention versus bypass surgery from a Dutch perspective.
Osnabrugge RL, Magnuson EA, Serruys PW, Campos CM, Wang K, van Klaveren D, Farooq V, Abdallah MS, Li H, Vilain KA, Steyerberg EW, Morice MC, Dawkins KD, Mohr FW, Kappetein AP, Cohen DJ; SYNTAX trial investigators. Osnabrugge RL, et al. Among authors: abdallah ms. Heart. 2015 Dec;101(24):1980-8. doi: 10.1136/heartjnl-2015-307578. Epub 2015 Nov 9. Heart. 2015. PMID: 26552756 Clinical Trial.
Cost-effectiveness of percutaneous coronary intervention with drug eluting stents versus bypass surgery for patients with diabetes mellitus and multivessel coronary artery disease: results from the FREEDOM trial.
Magnuson EA, Farkouh ME, Fuster V, Wang K, Vilain K, Li H, Appelwick J, Muratov V, Sleeper LA, Boineau R, Abdallah M, Cohen DJ; FREEDOM Trial Investigators. Magnuson EA, et al. Circulation. 2013 Feb 19;127(7):820-31. doi: 10.1161/CIRCULATIONAHA.112.147488. Epub 2012 Dec 31. Circulation. 2013. PMID: 23277307 Free PMC article. Clinical Trial.
Cost-effectiveness of percutaneous coronary intervention with drug-eluting stents versus bypass surgery for patients with 3-vessel or left main coronary artery disease: final results from the Synergy Between Percutaneous Coronary Intervention With TAXUS and Cardiac Surgery (SYNTAX) trial.
Cohen DJ, Osnabrugge RL, Magnuson EA, Wang K, Li H, Chinnakondepalli K, Pinto D, Abdallah MS, Vilain KA, Morice MC, Dawkins KD, Kappetein AP, Mohr FW, Serruys PW; SYNTAX Trial Investigators. Cohen DJ, et al. Among authors: abdallah ms. Circulation. 2014 Sep 30;130(14):1146-57. doi: 10.1161/CIRCULATIONAHA.114.009985. Epub 2014 Aug 1. Circulation. 2014. PMID: 25085960 Clinical Trial.
Quality of Life After Surgery or DES in Patients With 3-Vessel or Left Main Disease.
Abdallah MS, Wang K, Magnuson EA, Osnabrugge RL, Kappetein AP, Morice MC, Mohr FA, Serruys PW, Cohen DJ; SYNTAX Trial Investigators. Abdallah MS, et al. J Am Coll Cardiol. 2017 Apr 25;69(16):2039-2050. doi: 10.1016/j.jacc.2017.02.031. J Am Coll Cardiol. 2017. PMID: 28427580 Free article. Clinical Trial.
Management of coronary chronic total occlusion.
Khatri J, Abdallah M, Ellis S. Khatri J, et al. Cleve Clin J Med. 2017 Dec;84(12 Suppl 3):27-38. doi: 10.3949/ccjm.84.s3.03. Cleve Clin J Med. 2017. PMID: 29257736 Free article. Review.
Coronary Artery Target Selection and Survival After Bilateral Internal Thoracic Artery Grafting.
Bakaeen FG, Ravichandren K, Blackstone EH, Houghtaling PL, Soltesz EG, Johnston DR, Mick SL, Navia JL, Tong MZ, McCurry KR, Akhrass R, Abdallah M, Pettersson GB, Smedira NM, Roselli EE, Gillinov AM, Svensson LG. Bakaeen FG, et al. J Am Coll Cardiol. 2020 Jan 28;75(3):258-268. doi: 10.1016/j.jacc.2019.11.026. J Am Coll Cardiol. 2020. PMID: 31976863 Free article.
Insulin resistance is associated with significant clinical atherosclerosis in nondiabetic patients with acute myocardial infarction.
Karrowni W, Li Y, Jones PG, Cresci S, Abdallah MS, Lanfear DE, Maddox TM, McGuire DK, Spertus JA, Horwitz PA. Karrowni W, et al. Among authors: abdallah ms. Arterioscler Thromb Vasc Biol. 2013 Sep;33(9):2245-51. doi: 10.1161/ATVBAHA.113.301585. Epub 2013 Jul 18. Arterioscler Thromb Vasc Biol. 2013. PMID: 23868937 Free PMC article.
80 results